La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes Hydrating Protective Cream SPF 29
Dosage form: lotion
Ingredients: Octinoxate 1.125mL in 15mL, Titanium dioxide 1.14mL in 15mL
Labeler: Laboratoires Industriels de Vichy (LIDV)
NDC Code: 66382-157
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Octinoxate 7.5%
Titanium dioxide 5.6%
Uses
- helps prevent sunburn
- higher SPF gives more sunburn protection
- protects against UVA/UVB rays
Directions
- apply evenly before sun exposure and as needed
- children under 6 months of age: ask a doctor
Warnings
For external use only
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash or irritation develops and lasts
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
| LA ROCHE-POSAY LABORATOIRE PHARMACETIQUE HYDRAPHASE UV EYES
HYDRATING PROTECTIVE CREAM SPF 29
octinoxate titanium dioxide lotion |
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
| Labeler - Laboratoires Industriels de Vichy (LIDV) (282658798) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Laboratoires Industriels de Vichy (LIDV) | 282658798 | manufacture | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
